BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37118722)

  • 21. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node metastasis and its risk factors in T1 lung adenocarcinoma.
    Zhang W; Mu G; Huang J; Bian C; Wang H; Gu Y; Xia Y; Chen L; Yuan M; Wang J
    Thorac Cancer; 2023 Oct; 14(30):2993-3000. PubMed ID: 37667435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer.
    Bao F; Zhao LY; Balde AI; Liu H; Yan J; Li TT; Chen H; Li GX
    Colorectal Dis; 2016 Sep; 18(9):O322-9. PubMed ID: 27438774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of prognosis and influencing factors of No. 253 lymph node metastasis in descending colon, sigmoid colon, and rectal cancer: a multicenter study].
    Zhao FQ; Zhou L; Du XH; Wu AW; Yang H; Xu L; Liu XZ; Hu SD; Xiao Y; Liu Q
    Zhonghua Wai Ke Za Zhi; 2023 Sep; 61(9):760-767. PubMed ID: 37491168
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
    Liu C; Wei S; Guo C; Mei J; Pu Q; Liu L
    Ann Surg Oncol; 2021 Jan; 28(1):194-202. PubMed ID: 32638165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
    Zheng Y; Ju S; Huang R; Zhao J
    J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis.
    Schlachtenberger G; Schallenberg S; Doerr F; Menghesha H; Gaisendrees C; Amorin A; Grathwohl C; Büttner R; Quaas A; Horst D; Klauschen F; Frost N; Rueckert JC; Neudecker J; Höpker K; Wahlers T; Hekmat K; Heldwein MB
    Eur J Cardiothorac Surg; 2023 Jul; 64(1):. PubMed ID: 37369037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
    Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
    J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study.
    Park BJ; Kim TH; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Cho JH
    J Thorac Oncol; 2019 Nov; 14(11):1962-1969. PubMed ID: 31442497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does anatomical location-based metastatic lymph node density affect prognosis in lung cancer patients?
    Aksoy Y; Çıtak N; Obuz Ç; Metin M; Sayar A
    Interact Cardiovasc Thorac Surg; 2021 Oct; 33(4):541-549. PubMed ID: 34000035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Yang H; Mei T
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of apical lymph node metastasis in right colon cancer.
    Wang LM; Hirano YM; Ishii TM; Kondo HK; Hara KK; Obara N; Asari MH; Yamaguchi SK
    Int J Colorectal Dis; 2020 Oct; 35(10):1887-1894. PubMed ID: 32514722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis.
    Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F
    Clin Lung Cancer; 2020 Sep; 21(5):464-471.e1. PubMed ID: 32389508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
    BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.